Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
NASA is sending astronauts back to the moon. Can you see the Artemis 4 landing sites from Earth? - 2A definitive Manual for 2024's Most In vogue Wedding Dresses
- 3PHOTO ESSAY: Scientists trying to unravel one of the body's biggest mysteries
- 4Tourist trade in Greece and Cyprus suffering from Iran war effects
- 5What were the little white pills found in Tiger Woods's pocket at the scene of his crash? What to know about hydrocodone.
- Best Amusement Park in Europe: Where Do You Very much want to Visit?
- The 10 Most Compelling Forerunners in Innovation
- Which Diet Prompts the Incomparable Wellbeing Results?
- Telescope in Chile captures stunning new picture of a cosmic butterfly
- Zelensky sees win for Ukraine as EU finally reaches funding deal
- What we know about the Brown University shooting suspect who was found dead, and how police linked him to the MIT killing
- Figure out How to Involve a Brain science Certification in Showcasing
- Attacks on Iran's Bushehr nuclear plant and on Iraq border crossing
- From Educational Loans to Obligation Free: Independence from the rat race Accomplished
